DUBLIN , June 8, 2022 /PRNewswire/ -- The "Pharmaceutical Glass Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical glass packaging market reached a value of US$ 8.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 12.63 Billion by 2027 exhibiting a CAGR of 7.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Glass is widely utilized as a packaging material for various pharmaceutical products. Some commonly used pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, and general-purpose soda-lime glass. It restricts atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, thus eliminating the risk of contamination of the medicines.

It also helps extend the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing drug stability. Moreover, colored glass, such as amber and red-colored glass, can protect the contents from ultraviolet (UV) rays and specific wavelengths. In recent years, pharmaceutical glass packaging has rapidly gained traction due to its excellent strength, durability, transparency, recyclability, and chemical resistance. Pharmaceutical glass packaging protects the contents against physical damage, prevents biological contamination, and reduces the drug's susceptibility to degradation, such as hydrolysis and oxidation. As a result, the expanding pharmaceutical industry represents the primary factor driving the market growth.

Additionally, the growing need to extend the shelf life of medicinal products and the rising consumption of generic drugs and injectables are augmenting the product demand. Besides this, the widespread prevalence of chronic diseases like diabetes, increasing healthcare awareness among the masses, and elevating income levels are catalyzing the market growth.

Furthermore, governments of various countries are taking several favorable initiatives to encourage the usage of recycled glass to reduce the carbon footprint and ensure a safer and greener environment. Along with this, the launch of thin and lightweight glass bottles by leading manufacturers to minimize the overall consumption of energy and raw materials is propelling the market growth.

Other factors, including the emerging applications of glass bottles, improving healthcare infrastructure, rising environmental concerns, ongoing research and development (R&D) activities, and technological advancements, are also providing a positive thrust to the market growth.

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam (Turkiye Is Bankasi A.S.), Stolzle-Oberglas GmBH and West Pharmaceutical Services Inc. Key Questions Answered in This Report:

How has the global pharmaceutical glass packaging market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?

What are the key regional markets?

What is the breakup of the market based on the product?

What is the breakup of the market based on the drug type?

What is the breakup of the market based on the application?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global pharmaceutical glass packaging market and who are the key players?

What is the degree of competition in the industry?

Key Topics Covered: 1 Preface 2 Scope and Methodology

3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Pharmaceutical Glass Packaging Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Bottles 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Vials 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Ampoules 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Cartridges and Syringes 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Drug Type 7.1 Generic 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Branded 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Biologic 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Injectable 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Nasal 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Ardagh Group S.A 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Beatson Clark 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bormioli Pharma S.p.A. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Corning Incorporated 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Gerresheimer AG 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.6 Nipro Corporation 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Piramal Enterprises Ltd. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.8 Schott AG 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 SWOT Analysis 14.3.9 SGD Pharma 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Shandong Pharmaceutical Glass Co. Ltd. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 ?i?ecam (Turkiye ?? Bankas? A.?.) 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.12 Stolzle-Oberglas GmBH 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.13 West Pharmaceutical Services Inc. 14.3.13.1 Company Overview 14.3.13.2 Product Portfolio 14.3.13.3 Financials 14.3.13.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/648uuv

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/insights-on-the-pharmaceutical-glass-packaging-global-market-to-2027---by-product-drug-type-application-and-region-301564021.html

Bridgewater’s co–chief investment officer said the U.S. economy could slow down further.

The rate of U.S. inflation reached a 40-year high of 8.6% in May as overall prices for things including rent, gas and food all remain on the rise. “I personally believe that this inflation is here to stay for quite some time,” Orman recently told CNBC, prior to the release of May’s CPI data from the U.S. Bureau of Labor Statistics. The first is a fixed rate when the purchaser buys the bond, and the second is the inflation adjustment rate, which is reset every six months based on inflation.

Yahoo Finance Live’s Brian Sozzi, Brad Smith, and Julie Hyman discuss quarterly earnings for DocuSign.

The U.S. hasn't yet entered a recession -- which is officially defined as two consecutive quarters of negative GDP growth -- but runaway inflation, stagnant wages, food shortages, rising interest rates, and geopolitical turmoil could all break this fragile economy's back in the near future. If that happens, growth stocks will fall further as value stocks become even more attractive. Altria is the top tobacco company in America.

(Bloomberg) -- Former Treasury Secretary Lawrence Summers said the Federal Reserve has failed to account for its mistakes and to realize the damage to its credibility after the latest inflation data dashed hopes that a peak had been reached.Most Read from BloombergUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenUS Lifts Covid-19 Test Requirement for International TravelEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot He

ChargePoint, Autoliv, and QuantumScape look like excellent long-term bets, despite the near-term headwinds they face.

What to do in today’s market? The last few trading sessions of declining stocks would seem to indicate that the late-May rally we saw has run its course. But that doesn’t mean the opportunities for buy-minded investors are all gone. The recent declines, and the overall downward trend we’ve seen year-to-date, have left many fundamentally sound stocks trading at rock bottom prices. And that may have created an opportunity for investors willing do a bit of bottom fishing. The trick for investors, h

Be greedy (but selective) when others are fearful.

Oil prices sank on Friday, after U.S. consumer prices rose more than expected and China imposed new COVID-19 lockdown measures. Brent crude fell $2.12, or 1.7%, to $120.95 a barrel at 12:42 p.m. EDT (1642 GMT). For the day, oil prices sank along with Wall Street stocks after news that U.S. consumer prices accelerated in May. Gasoline prices have hit a record high and the cost of food has soared, leading to the largest annual increase in about 40 years.

Markets are volatile. Use these dividend stocks for peace of mind.

Inflation has yet to peak and has only gotten worse since 2021, Tim Magnusson, chief investment officer of Garda Capital Partners, tells MarketWatch.

The bears have killed Carvana's share price this year, but don't be surprised if its stock gets back on the road to growth.

Inflation remains white-hot. These stocks can help stop the pain.

The relaunch will begin on Russia Day, a patriotic holiday celebrating the country's independence, at the same flagship location in Moscow's Pushkin Square where McDonald's first opened in Russia in January 1990. In the early 1990s, as the Soviet Union crumbled, McDonald's came to embody a thawing of Cold War tensions and was a vehicle for millions of Russians to sample American food and culture. The brand's exit is now a powerful symbol of how Russia and the West are once again turning their backs on each other.

In this article, we will take a look at the 8 best tech stocks to buy according to Bank of America. You can skip our analysis of the bank’s overall outlook on the tech sector and go directly to the 4 Best Tech Stocks to Buy According to Bank of America. In a detailed note issued […]

(Bloomberg) -- Traders are now fully pricing three half-point Federal Reserve rate hikes in coming months, while the 30-year Treasury yield fell below its five-year counterpart for the first time in a month. Most Read from BloombergUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenUS Lifts Covid-19 Test Requirement for International TravelEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot HearingWhy Inflation Is Hitting Ame

Want to bet on a bounce? Consider these three stocks first.

While Apple, Nvidia, Microsoft and GOOGL stock have gone MIA, the best mutual funds bet big on medical, defense and oil stocks.

A top executive at Walt Disney is leaving nearly a year after renewing his contract in what might be just the latest headache for the entertainment giant and its stock. The media giant said Thursday that Dana Walden would succeed Peter Rice as chairman of general entertainment content, effective immediately. Rice joined Disney (ticker: DIS) in 2019 as part of the 21st Century Fox acquisition.

Friday’s consumer-price index report for May — which showed the annual headline U.S. inflation rate climbing to 8.6% in May, with few signs of having peaked — is boosting the chances of a jumbo-sized rate increase by monetary-policy makers as soon as next week, and eliciting dire warnings that central bankers have completely lost control of prices. Fed funds futures traders now see a 21% chance of a 75-basis-point hike in June, up from just 3.6% on Thursday, according to the CME FedWatch Tool. Beneath the issue of where the Fed goes from here is a much more fundamental and serious problem: Some observers fear the U.S. central bank has already effectively lost control of inflation.